Published on March 26, 2026
The attorneys general of Texas and Arizona have filed a lawsuit against Cord Blood Registry (CBR), a company that specializes in the storage of umbilical cord blood cells, alleging that the firm engaged in false advertising to lure new parents into purchasing its services. This legal action underscores concerns that the company misled families about the potential benefits and uses of cord blood stem cells.
According to the complaint, CBR is accused of making exaggerated claims about the likelihood of children benefiting from stored cord blood later in life, suggesting that it could treat a variety of ailments without sufficient scientific backing. The lawsuit contends that such misleading representations not only inflating the potential health benefits but also encouraged parents to spend significant amounts of money—often several thousand dollars—for services that may not provide the promised advantages.
“Parents deserve to make informed decisions based on accurate information,” said Texas Attorney General Ken Paxton. “Deceptive practices that exploit new parents’ hopes and concerns are not only unethical but also illegal.” Arizona Attorney General Kris Mayes echoed these sentiments, asserting that CBR’s actions have taken advantage of expectant families during a vulnerable time.
As part of the legal proceedings, the states are seeking restitution for affected consumers and penalties against CBR for its business practices. They hope this lawsuit will serve as a warning to other companies operating in the health and wellness space about the importance of transparency and truthfulness in advertising.
Cord Blood Registry has defended its marketing practices, maintaining that it provides valuable services that have helped numerous families. The company asserts that the lawsuit misrepresents its communications with parents and undermines the legitimate health benefits associated with cord blood. CBR has stated that they intend to fight the allegations vigorously.
This case is being closely watched groups and regulatory agencies, as it raises broader questions about accountability in the burgeoning field of stem cell therapy and the ethical considerations of marketing medical services to families. The outcome may also influence the way cord blood banking is regulated in the future and could prompt other states to examine similar practices storage companies.
As a growing number of parents consider cord blood banking as a precautionary measure for their newborns, the implications of this lawsuit could resonate throughout the industry, potentially altering how companies communicate with consumers and the claims they make about their services.
Related News
- What The Sandhill Cranes Taught Me On The Platte
- New York City’s Population Flat After Drop in Immigration
- Silvio Rodríguez: ‘The world is run by an authoritarian, warmongering, thieving regime. And it’s not Cuba’
- Reflexiones alrededor del revuelo con la nueva versión de Cumbres borrascosas (Wuthering Heights, 2026) de Emerald Fennell
- Stephen Colbert goes from late night to 'Lord of the Rings': Host set to co-write new movie script
- Prepare for turbulence – how a prolonged Middle East conflict could reshape how we fly